Literature DB >> 21154522

Discounting future health benefits: the poverty of consistency arguments.

Erik Nord1.   

Abstract

In economic evaluation of health care, main stream practice is to discount benefits at the same rate as costs. But main papers in which this practice is advocated have missed a distinction between two quite different evaluation problems: (1) How much does the time of program occurrence matter for value and (2) how much do delays in health benefits from programs implemented at a given time matter? The papers have furthermore focused on logical and arithmetic arguments rather than on real value considerations. These 'consistency arguments' are at best trivial, at worst logically flawed. At the end of the day, there is a sensible argument for equal discounting of costs and benefits rooted in microeconomic theory of rational, utility maximising consumers' saving behaviour. But even this argument is problematic, first because the model is not clearly supported by empirical observations of individuals' time preferences for health, second because it relates only to evaluation in terms of overall individual utility. It does not provide grounds for claiming that decision makers with a wider societal perspective, which may include concerns for fair distribution, need to discount
Copyright © 2010 John Wiley & Sons, Ltd. 2010 John Wiley & Sons, Ltd.

Mesh:

Year:  2010        PMID: 21154522     DOI: 10.1002/hec.1687

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  9 in total

1.  Discounting, preferences, and paternalism in cost-effectiveness analysis.

Authors:  Gustav Tinghög
Journal:  Health Care Anal       Date:  2012-09

2.  Discounting the Recommendations of the Second Panel on Cost-Effectiveness in Health and Medicine.

Authors:  Mike Paulden; James F O'Mahony; Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2017-01       Impact factor: 4.981

3.  Reducing older driver motor vehicle collisions via earlier cataract surgery.

Authors:  Stephen T Mennemeyer; Cynthia Owsley; Gerald McGwin
Journal:  Accid Anal Prev       Date:  2013-01-11

4.  Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease--a cost-effectiveness analysis.

Authors:  Torbjørn Wisløff; Randi M Selmer; Sigrun Halvorsen; Atle Fretheim; Ole F Norheim; Ivar Sønbø Kristiansen
Journal:  BMC Cardiovasc Disord       Date:  2012-04-04       Impact factor: 2.298

5.  Cost-effectiveness and affordability of community mobilisation through women's groups and quality improvement in health facilities (MaiKhanda trial) in Malawi.

Authors:  Tim Colbourn; Anni-Maria Pulkki-Brännström; Bejoy Nambiar; Sungwook Kim; Austin Bondo; Lumbani Banda; Charles Makwenda; Neha Batura; Hassan Haghparast-Bidgoli; Rachael Hunter; Anthony Costello; Gianluca Baio; Jolene Skordis-Worrall
Journal:  Cost Eff Resour Alloc       Date:  2015-01-10

6.  Methods to construct a step-by-step beginner's guide to decision analytic cost-effectiveness modeling.

Authors:  Tamlyn Rautenberg; Claire Hulme; Richard Edlin
Journal:  Clinicoecon Outcomes Res       Date:  2016-10-11

7.  Accounting for Timing when Assessing Health-Related Policies.

Authors:  Karl Claxton; Miqdad Asaria; Collins Chansa; Julian Jamison; James Lomas; Jessica Ochalek; Mike Paulden
Journal:  J Benefit Cost Anal       Date:  2019-01-26

8.  High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention.

Authors:  Ivanny Marchant; Jean-Pierre Boissel; Patrice Nony; François Gueyffier
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

9.  Differential discounting in the economic evaluation of healthcare programs.

Authors:  Jürgen John; Florian Koerber; Mareike Schad
Journal:  Cost Eff Resour Alloc       Date:  2019-12-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.